DOW JONES23,433.57+779.71 3.44%
S&P 5002,749.98+90.57 3.41%
NASDAQ8,090.90+203.64 2.58%

INmune Bio Q4 EPS $(0.22) Beats $(0.25) Estimate

INmune Bio (NASDAQ:INMB) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.25) by 12 percent.

Benzinga · 03/11/2020 13:14

INmune Bio (NASDAQ:INMB) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.25) by 12 percent.